Fig. 6From: Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplexImmune activationin vivo. (A) Percentage of CD45+ CD3+ CD8+ cells in lymphocytes after different treatments. (B) Percentage of PD-1+ Tim-3+ cells in T cells after different treatments. (C) Percentage of CD11b+ Gr-1+ cells in liver after different treatments. (D) TNF-α, IFN-γ, IL-10, and TGF-β levels in plasma after different treatmentsBack to article page